GB1499672A - Tablet formulation - Google Patents
Tablet formulationInfo
- Publication number
- GB1499672A GB1499672A GB6758/74A GB675874A GB1499672A GB 1499672 A GB1499672 A GB 1499672A GB 6758/74 A GB6758/74 A GB 6758/74A GB 675874 A GB675874 A GB 675874A GB 1499672 A GB1499672 A GB 1499672A
- Authority
- GB
- United Kingdom
- Prior art keywords
- potentiator
- mixture
- weight
- meaning given
- tablet formulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
Abstract
2,4-Diamino-5-benzylpyrimidines of the accompanying formula I, in which R<1>, R<2> and R<3> have the meaning given in the Patent Claim, which are contained as a potentiator for sulphonamides in tablets in which a mixture of sulphonamide and potentiator is present in an amount of 80 to 95% by weight, the mixture having a particle size of less than 40 mu m, and which additionally contain a granulating agent and a disintegrating agent which has a swelling capacity of more than 5 ml/g, the total amount of the two agents being not more than 20% by weight, are prepared by reacting a compound of the accompanying formula II, in which X, Y and Z have the meaning given in the Patent Claim, with guanidine and purifying and isolating the process product. <IMAGE>
Priority Applications (35)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB6758/74A GB1499672A (en) | 1974-02-14 | 1974-02-14 | Tablet formulation |
LU71835A LU71835A1 (en) | 1974-02-14 | 1975-02-13 | |
ZA00750930A ZA75930B (en) | 1974-02-14 | 1975-02-13 | Tablet formulation |
NL7501680.A NL157501C (en) | 1974-02-14 | 1975-02-13 | PHARMACEUTICAL TABLET CONTAINING A COMBINATION OF A 2,4-DIAMINO-5-BENZYL-PYRIMIDINE DERIVATIVE WITH A SULFONAMIDE, BOTH MICRONIZED, IN ADDITION TO AT LEAST A SPLIT AND A GRANULATOR, AT THE SAME TIME, AT THE SAME TIME. |
IE278/75A IE40599B1 (en) | 1974-02-14 | 1975-02-13 | Tablet formulation |
SE7501595A SE427898B (en) | 1974-02-14 | 1975-02-13 | SET TO PREPARE TABLES WITH SHORT SUBDIVISION TIME INCLUDING 2,4-DIAMINO-5- (3,4,5-TRIMETOXYBENZYL) PYRIMIDINE AND 3- (4-AMINOBENZENSULPHONAMIDO) -5-METHYLISOXAZOLE |
AU78170/75A AU468465B2 (en) | 1974-02-14 | 1975-02-13 | Tablet formulation |
IN270/CAL/75A IN141019B (en) | 1974-02-14 | 1975-02-13 | |
AT108475A AT344915B (en) | 1974-02-14 | 1975-02-13 | METHOD FOR PRODUCING TABLETS |
CH174775A CH618432A5 (en) | 1974-02-14 | 1975-02-13 | Process for the preparation of a 2,4-diamino-5-benzylpyrimidine intended for the production of tablets |
CY1052A CY1052A (en) | 1974-02-14 | 1975-02-13 | Tablet formulation |
CA219,982A CA980688A (en) | 1974-02-14 | 1975-02-13 | Tablet formulation |
ZM18/75A ZM1875A1 (en) | 1974-02-14 | 1975-02-13 | Tablet formulation |
FR7504470A FR2260993B1 (en) | 1974-02-14 | 1975-02-13 | |
MC751136A MC1053A1 (en) | 1974-02-14 | 1975-02-13 | MEDICINAL PRODUCT CONTAINING A 2,4-DIAMINO-PYRIMIDINE ER A SULFONAMIDE T A SULFONAMIDE |
BE153330A BE825496A (en) | 1974-02-14 | 1975-02-13 | TABLETS CONTAINING A COMBINATION OF 2,4-DIAMINOPYRIMIDINE WITH SULFONAMIDE |
FI750398A FI62219C (en) | 1974-02-14 | 1975-02-13 | FOER FARING FOER FRAMSTAELLNING AV SNABBT SOENDERFALLANDE TABLETTER |
JP1838875A JPS5545043B2 (en) | 1974-02-14 | 1975-02-13 | |
ES434688A ES434688A1 (en) | 1974-02-14 | 1975-02-13 | Tablet formulation |
CS75927A CS220306B2 (en) | 1974-02-14 | 1975-02-13 | Method of manufacturing tablets having short breakdown period |
IL46629A IL46629A (en) | 1974-02-14 | 1975-02-13 | Tablets comprising a 2,4-diaminopyrimidine and a sulphonamide |
HU75WE00000519A HU171536B (en) | 1974-02-14 | 1975-02-13 | Process for producing tablets, containing sulfonamide and diaminopyrimidine |
DE2506099A DE2506099C2 (en) | 1974-02-14 | 1975-02-13 | Tablet containing sulfonamide and trimethoprim |
DK52875A DK143247C (en) | 1974-02-14 | 1975-02-13 | MEDICAL TABLET CONTAINING AS ACTIVE INGREDIENT A 2,4-DIAMINO-5-BENZYLPYRIMIDINE WITH A SULPHONAMIDE |
PH16805A PH14575A (en) | 1974-02-14 | 1975-02-13 | An improved tablet formulation |
DD184168A DD118228A5 (en) | 1974-02-14 | 1975-02-13 | |
NO750467A NO146043C (en) | 1974-02-14 | 1975-02-13 | PROCEDURE FOR THE PREPARATION OF TABLETS WITH SHORT DECOMPOSITION TIME |
ZM2976A ZM2976A1 (en) | 1974-02-14 | 1976-03-10 | Tablet formulation |
MC1136K MC181A7 (en) | 1974-02-14 | 1976-04-09 | MEDICINAL PRODUCT CONTAINING A 2,4-DIAMINO-PYRIMIDINE E |
US05/896,297 US4209513A (en) | 1974-02-14 | 1978-04-14 | Tablet formulation |
DO1979002763A DOP1979002763A (en) | 1974-02-14 | 1979-05-14 | A METHOD FOR PREPARING A TABLET OF A PHARMACEUTICAL FORMULATION |
GT197960431A GT197960431A (en) | 1974-02-14 | 1979-11-12 | FORMULATION OF BASE TABLETS OF 2,4-DIAMINO-5-BENCILPIRI-MIDINA AND A SULFONAMIDE SUITABLE FOR ORAL ADMINISTRATION. |
KE3038A KE3038A (en) | 1974-02-14 | 1980-03-28 | Tablet formulation |
HK239/80A HK23980A (en) | 1974-02-14 | 1980-05-01 | Tablet formulation |
MY54/81A MY8100054A (en) | 1974-02-14 | 1981-12-30 | Tablet formulation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB6758/74A GB1499672A (en) | 1974-02-14 | 1974-02-14 | Tablet formulation |
Publications (1)
Publication Number | Publication Date |
---|---|
GB1499672A true GB1499672A (en) | 1978-02-01 |
Family
ID=9820242
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB6758/74A Expired GB1499672A (en) | 1974-02-14 | 1974-02-14 | Tablet formulation |
Country Status (32)
Country | Link |
---|---|
JP (1) | JPS5545043B2 (en) |
AT (1) | AT344915B (en) |
AU (1) | AU468465B2 (en) |
BE (1) | BE825496A (en) |
CA (1) | CA980688A (en) |
CH (1) | CH618432A5 (en) |
CS (1) | CS220306B2 (en) |
CY (1) | CY1052A (en) |
DD (1) | DD118228A5 (en) |
DE (1) | DE2506099C2 (en) |
DK (1) | DK143247C (en) |
DO (1) | DOP1979002763A (en) |
ES (1) | ES434688A1 (en) |
FI (1) | FI62219C (en) |
FR (1) | FR2260993B1 (en) |
GB (1) | GB1499672A (en) |
GT (1) | GT197960431A (en) |
HK (1) | HK23980A (en) |
HU (1) | HU171536B (en) |
IE (1) | IE40599B1 (en) |
IL (1) | IL46629A (en) |
IN (1) | IN141019B (en) |
KE (1) | KE3038A (en) |
LU (1) | LU71835A1 (en) |
MC (1) | MC1053A1 (en) |
MY (1) | MY8100054A (en) |
NL (1) | NL157501C (en) |
NO (1) | NO146043C (en) |
PH (1) | PH14575A (en) |
SE (1) | SE427898B (en) |
ZA (1) | ZA75930B (en) |
ZM (1) | ZM1875A1 (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4434152A (en) | 1981-04-28 | 1984-02-28 | Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt. | Time-release |
US5190760A (en) * | 1989-07-08 | 1993-03-02 | Coopers Animal Health Limited | Solid pharmaceutical composition |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1533243A (en) * | 1975-02-13 | 1978-11-22 | Wellcome Found | Tablet formulation |
US4115563A (en) * | 1977-03-14 | 1978-09-19 | Sterling Drug Inc. | Pharmaceutical steroid formulation |
GB1601833A (en) * | 1978-02-06 | 1981-11-04 | Wellcome Found | Antacid formulation |
GB8603964D0 (en) * | 1986-02-18 | 1986-03-26 | Cooper Animal Health Ltd | Compositions |
GB8915716D0 (en) * | 1989-07-08 | 1989-08-31 | Coopers Animal Health | Pharmaceutical compositions |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1445983A (en) * | 1972-11-06 | 1976-08-11 | Wellcome Found | Pharmaceutical formulations |
-
1974
- 1974-02-14 GB GB6758/74A patent/GB1499672A/en not_active Expired
-
1975
- 1975-02-13 ES ES434688A patent/ES434688A1/en not_active Expired
- 1975-02-13 CS CS75927A patent/CS220306B2/en unknown
- 1975-02-13 FI FI750398A patent/FI62219C/en not_active IP Right Cessation
- 1975-02-13 IN IN270/CAL/75A patent/IN141019B/en unknown
- 1975-02-13 CY CY1052A patent/CY1052A/en unknown
- 1975-02-13 CH CH174775A patent/CH618432A5/en not_active IP Right Cessation
- 1975-02-13 JP JP1838875A patent/JPS5545043B2/ja not_active Expired
- 1975-02-13 FR FR7504470A patent/FR2260993B1/fr not_active Expired
- 1975-02-13 ZM ZM18/75A patent/ZM1875A1/en unknown
- 1975-02-13 IE IE278/75A patent/IE40599B1/en unknown
- 1975-02-13 SE SE7501595A patent/SE427898B/en not_active IP Right Cessation
- 1975-02-13 DK DK52875A patent/DK143247C/en not_active IP Right Cessation
- 1975-02-13 HU HU75WE00000519A patent/HU171536B/en unknown
- 1975-02-13 LU LU71835A patent/LU71835A1/xx unknown
- 1975-02-13 AT AT108475A patent/AT344915B/en not_active IP Right Cessation
- 1975-02-13 CA CA219,982A patent/CA980688A/en not_active Expired
- 1975-02-13 BE BE153330A patent/BE825496A/en not_active IP Right Cessation
- 1975-02-13 NL NL7501680.A patent/NL157501C/en not_active IP Right Cessation
- 1975-02-13 ZA ZA00750930A patent/ZA75930B/en unknown
- 1975-02-13 PH PH16805A patent/PH14575A/en unknown
- 1975-02-13 MC MC751136A patent/MC1053A1/en unknown
- 1975-02-13 DE DE2506099A patent/DE2506099C2/en not_active Expired
- 1975-02-13 DD DD184168A patent/DD118228A5/xx unknown
- 1975-02-13 IL IL46629A patent/IL46629A/en unknown
- 1975-02-13 AU AU78170/75A patent/AU468465B2/en not_active Expired
- 1975-02-13 NO NO750467A patent/NO146043C/en unknown
-
1979
- 1979-05-14 DO DO1979002763A patent/DOP1979002763A/en unknown
- 1979-11-12 GT GT197960431A patent/GT197960431A/en unknown
-
1980
- 1980-03-28 KE KE3038A patent/KE3038A/en unknown
- 1980-05-01 HK HK239/80A patent/HK23980A/en unknown
-
1981
- 1981-12-30 MY MY54/81A patent/MY8100054A/en unknown
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4434152A (en) | 1981-04-28 | 1984-02-28 | Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara Rt. | Time-release |
US5190760A (en) * | 1989-07-08 | 1993-03-02 | Coopers Animal Health Limited | Solid pharmaceutical composition |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS5632440A (en) | Propenylamines* their manufacture* pharmaceutic composition containing them and their use as medicine | |
JPS57180602A (en) | Production of water-soluble chitosan derivative and film-forming agent comprising same | |
GB1499672A (en) | Tablet formulation | |
ES8406448A1 (en) | Substituted phenylsulfonyloxybenzimidazole carbamates, process for their preparation and their application as medicaments. | |
IL38972A (en) | Substituted phenyl alkanol derivatives,their preparation and compositions containing them | |
JPS552601A (en) | Anti-tumor agent for non-injection use | |
ES8103026A1 (en) | Peptides having ubiquitin-like activity, process for their preparation, therapeutic compositions containing them and their use. | |
DE2965574D1 (en) | Adamantylalkyloxy-carbonyl derivatives, their preparation and their use for the production of peptides | |
ES8401946A1 (en) | Sulphonyl ureas, process for their preparation, pharmaceutical compositions containing them and their use. | |
IE41444L (en) | Pharmaceutical compositions containing cinnamamides | |
IE44041L (en) | Fire-extinguishing composition. | |
PT77285B (en) | Process for preparing substituted benzenosulphonates and pharmaceutical compositions containing the same | |
ES8308562A1 (en) | Polycyclic compounds containing a double bond in the D-ring pharmaceutical compositions containing them, and methods of treating psoriasis with them | |
GB1298587A (en) | Methods of contraception and contraceptive compositions | |
ES8502424A1 (en) | Benzazepine derivatives, process for their preparation and their use as pharmaceutical compounds. | |
GB1437788A (en) | Therapeutic compositions | |
GB1414602A (en) | Plastic refractory compositions | |
US2608513A (en) | Methyl-butylsulfamylbenzoic acid | |
IL60383A0 (en) | Cyclophosphathiazene derivatives,their preparation and pharmaceutical compositions containing them | |
US3063897A (en) | Analgesic compositions containing o-ethoxybenzamide with salicylamide or with a mixture of salicylamide and acetyl-p-aminophenol | |
AT353281B (en) | PROCESS FOR THE PREPARATION OF NEW 4- (BETA- -UREIDOAETHYL) -BENZENE-SULFONYL UREA AND THEIR SALTS | |
JPS55141438A (en) | Preparation of ground mono-basic aluminum acetylsalicylate | |
GB808071A (en) | Manufacture of new sulphonyl-ureas | |
JPS5758890A (en) | Preparation of glucosylmoranoline derivative | |
GB1312891A (en) | Composition containing penicillin salts |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PS | Patent sealed [section 19, patents act 1949] | ||
704A | Declaration that licence is not available as of right for an excepted use (par. 4a/1977) | ||
PE20 | Patent expired after termination of 20 years |
Effective date: 19950212 |